EXELIXIS, INC. (EXEL)
Clinical trial NCT05613894 updates: 1. status: RECRUITING → SUSPENDED 2. completion date: 2028-05-01 → 2028-12-01 3. primary completion date: 2026-05-01 → 2026-12-01
Clinical trial NCT05613894 updates: 1. status: RECRUITING → SUSPENDED 2. completion date: 2028-05-01 → 2028-12-01 3. primary completion date: 2026-05-01 → 2026-12-01
📉 **NEGATIVE** • Medium confidence analysis (73%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (18%) **Content type:** Clinical